Sjoerd Miedema
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sjoerd Miedema has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Dimitrina Georgieva
Sofia University “St. Kliment Ohridski”, Sofia, Bulgaria
1 shared publication- Kremena Naydenova
Medical University of Sofia, Sofia, Bulgaria
1 shared publication - Tsvetelina Velikova
Medical Faculty, Sofia University St. Kliment Ohridski, Sofia, Bulgaria
1 shared publication - Vasil Dimitrov
Clinic of Pulmonology and Allergology at the Medical Institute of the Ministry of Interior, Sofia, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 3 November 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-10
Gene expression of cytokines IL-17 and IL-33 in plasma and nasal lavage fluid of patients with allergic rhinitis and bronchial asthma
The research presented in this article determined the systemic (blood plasma) and local (nasal lavage fluid) levels of interleukin-17 (IL-17) and interleukin-33 (IL-33) in healthy volunteers, patients with allergic rhinitis (AR), and patients with both allergic rhinitis and recently diagnosed bronchial asthma (AR+BA). IL-17 and IL-33 levels were consistent between AR and AR+BA patients but diverged when comparing either patient group or the combined group of all patients with healthy volunteers. These results indicate that AR and AR+BA patients represent a homogeneous group and suggest a role for IL-17 and/or IL-33 in the progression of AR to AR+BA. In conclusion, our data show that patients with AR only and those who progress to AR+BA from AR alone have elevated IL-17 levels in both nasal lavage fluid (NLF) and serum. This finding is consistent with recent studies and identifies a novel population of AR+BA patients with elevated IL-17 levels. The possibility of novel IL-33 regulatory mechanisms in these patients warrants further research.
- 3 November 2025
- Published by Pensoft Publishers in Pharmacia
- Vol. 72, 1-10
Open AccessGene expression of cytokines IL-17 and IL-33 in plasma and nasal lavage fluid of patients with allergic rhinitis and bronchial asthma
The research presented in this article determined the systemic (blood plasma) and local (nasal lavage fluid) levels of interleukin-17 (IL-17) and interleukin-33 (IL-33) in healthy volunteers, patients with allergic rhinitis (AR), and patients with both allergic rhinitis and recently diagnosed bronchial asthma (AR+BA). IL-17 and IL-33 levels were consistent between AR and AR+BA patients but diverged when comparing either patient group or the combined group of all patients with healthy volunteers. These results indicate that AR and AR+BA patients represent a homogeneous group and suggest a role for IL-17 and/or IL-33 in the progression of AR to AR+BA. In conclusion, our data show that patients with AR only and those who progress to AR+BA from AR alone have elevated IL-17 levels in both nasal lavage fluid (NLF) and serum. This finding is consistent with recent studies and identifies a novel population of AR+BA patients with elevated IL-17 levels. The possibility of novel IL-33 regulatory mechanisms in these patients warrants further research.